Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 140 items

Cediranib (AZD2171) in Patients with Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Clinical Trial

Alberts, Steven R. , Fitch, Tom R. , Kim, George P. ... - - Am. J. Clin. Oncol. - 2012

Manuscript - Primary - Primary - GI - N044J

Gemcitabine and Doxetaxel for Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Clinical Trial

Alberts, Steven R. , Reid, Joel M. , Morlan, Bruce W. , Farr, Gist H. ... - - Am. J. Clin. Oncol. - 2012

Manuscript - Primary - Primary - GI - N0041

Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer

Alberts, Steven R. , Sargent, Daniel J. , Nair, Suresh ... - - JAMA - 2012

Manuscript - Primary - Primary - GI - N0147

Denileukin Diftitox in Combination with Rituximab for Previously Untreated Follicular B-cell Non-Hodgkin’s Lymphoma

Ansell, Stephen M. , Tang, Hui , Kurtin, Paul J. ... - - Leukemia - 2012

Manuscript - Primary - Primary - Lymphoma - NCCTG-N0682

External validation of prognostic models for overall survival (OS) in patients (pts) with advanced cancer (UC) treated with cisplatin-based chemotherapy.

Apolo, Andrea Borghese , Philips, George , Ostrovnaya, Irina ... - - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90102

Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993)

Atherton, Pamela J. , Burger, Kelli N. , Loprinzi, Charles L. ... - - Support Care Cancer - 2012

Manuscript - Primary - Primary - Symptom Inter - N0993

Measurement of Affective and Activity Pain Interference Using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903

Atkinson, Thomas M. , Halabi, Susan , Bennett, Antonia V. ... - - Pain Med - 2012

Manuscript - Primary - Primary - Health Outcome - CALGB-70903

A phase II study of bortezomib added to standard daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine (Int-DAC) for consolidation in patients with previously untreated acute myeloid leukemia (AML) age 60-75 years: CALGB study 10502.

Attar, E. C. , Johnson, J. L. , Amrein, P. C. , Lozanski, G. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Leukemia - CALGB-10502

A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101

Baldwin, R. Michael , Owzar, Kouros , Zembutsu, Hitoshi ... - - Clin. Cancer Res. - 2012

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

Phase III evaluation of American ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N07C2

Barton, D. L. , Liu, H. , Dakhil, S. R. , Linquist, B. M. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Symptom Inter - N07C2

Effect of age on the pharmacokinetics of busulfan (Bu): An Alliance study.

Beumer, J. H. , Lewis, L. D. , Owzar, K. , Jiang, C. , Holleran, J. L. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary - Primary - PPP - CALGB-10503 , CALGB-19808 , CALGB-100103

Maintenance Therapy with Decitabine in Younger Adults with Acute Myeloid Leukemia (AML) in First Remission: A Phase II Cancer and Leukemia Group B Study (CALGB 10503, Alliance)

Blum, W. , Sanford, B. , Klisovic, R. B. , Deangelo, D. J. , Uy, G. ... - ASH - Blood - 2012

Abstract - Primary - Primary - Leukemia - CALGB-10503

Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52

Bolton, J. S. , O'Connell, M. J. , Mahoney, M. R. , Farr, G. H. Jr ... - - Clin Colorectal Cancer - 2012

Manuscript - Primary - Primary - GI - NCCTG-924652

The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from the ACOSOG Z1071 trial

Boughey, J. , Suman, V. , Mittendorf, E. , Ahrendt, G. , Wilke, L. ... - - Cancer Res. - 2012

Abstract - Primary - Primary - Breast - ACOSOG-Z1071

LACE-Bio: validation of prognostic role of tumour lymphocytic infiltration in resectable non small cell lung cancer

Brambilla, E. , Domerg, C. , Lantuejoul, S. , Kratzke, R. ... - - J Thorac Oncol - 2012

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

Patient satisfaction with participation in phase II/III NCCTG clinical trials: Was it worth it? (N0392)

Chauhan, C. , Atherton, P. J. , Satele, D. , Dueck, A. C. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Health Outcome - NCCTG-N0392

Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia

Claus, R. , Lucas, D. M. , Stilgenbauer, S. , Ruppert, A. S. , Yu, L. ... - - J. Clin. Oncol. - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - C9712

Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803)

Cohen, Harvey Jay , Lan, Lan , Archer, Laura ... - - J Geriatr Oncol - 2012

Manuscript - Primary - Primary - Health Outcome - CALGB-70803

A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy in Node Negative Non-Small Cell Lung Cancer

Cuffe, Sinead , Bourredjem, Abderrahmane , Graziano, Stephen ... - - J Thorac Oncol - 2012

Manuscript - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness.

Czuczman, M S , Leonard, J P , Jung, S , Johnson, J L , Hsi, E D ... - - Ann. Oncol. - 2012

Manuscript - Primary - Primary - Lymphoma - CALGB-50402

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

Demmy, Todd L. , Gu, Lin , Burkhalter, Jack E. , Toloza, Eric M. ... - - J Natl Compr Canc Netw - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30102

A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502

Devine, S. M. , Owzar, K. , Blum, W. , Deangelo, D. , Stone, R. M. ... - ASH - ASH Annual Meeting Abstracts - 2012

Abstract - Primary - Primary - Transplant - CALGB-100103

Allosteric Akt inhibitor MK2206 synergizes with bendamustine in promoting the apoptosis of chronic lymphocytic leukemia cells and selectively targets B-cell receptor mediated cytokine production

Ding, W. , Shanafelt, T. D. , Lesnick, C. , Sassoon, T. , Secreto, C. ... - ASH - Blood - 2012

Abstract - Primary - Preliminary - Leukemia - N1087

Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report

Dudek, A. Z. , Pang, H. , Kratzke, R. A. , Otterson, G. A. ... - - J Thorac Oncol - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30601

Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Dueck, A. C. , Mendoza, T. R. , Mitchell, S. A. , Reeve, B. B. ... - - J. Clin. Oncol. - 2012

Abstract - No-Endpoint - Primary - Health Outcome - Comprehensive

N0821: A phase II first-line study of a combination of pemetrexed (P), carboplatin (C), and bevacizumab (B) in elderly patients with good performance status (PS < 2)

Dy, G. K. , Molina, J. , Qi, Y. , Ansari, R. H. , Thomas, S. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Respiratory - NCCTG-N0821

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

Edelman, Martin J. , Hodgson, Lydia , Rosenblatt, Paula Y. ... - - J Thorac Oncol - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150304

Heritable polymorphism predisposes to high expression of BAALC in cytogenetically normal acute myeloid leukemia (CN-AML)

Eisfeld, Ann-Kathrin , Marcucci, G. , Liyanarachchi, S. , Döhner, K. ... - AACR - AACR Annual Meeting - 2012

Abstract - Secondary - Primary - Leuk Corr Sci - C9665

Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia

Eisfeld, Ann-Kathrin , Marcucci, Guido , Liyanarachchi, Sandya ... - - Proc. Natl. Acad. Sci. U.S.A - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-9665

miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia

Eisfeld, Ann-Kathrin , Marcucci, Guido , Maharry, Kati ... - - Blood - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-9665

Whole-genome analysis informs breast cancer response to aromatase inhibition

Ellis, M. J. , Ding, L. , Shen, D. , Luo, J. Q. , Suman, V. J. ... - - Nature - 2012

Manuscript - Secondary-not-in-original - Comprehensive - PPP - ACOSOG-Z1031

Z1031B neoadjuvant aromatase inhibitor trial: A Phase 2 study of triage to chemotherapy based on 2 to 4 week Ki67 level >10%

Ellis, M. J. , Suman, V , McCall, L. , Luo, R. , Hoog, J. , Brink, A. ... - AACR - Cancer Res. - 2012

Abstract - Primary - Primary - Breast - ACOSOG-Z1031B

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657

Esserman, L. J. , Berry, D. A. , Demichele, A. , Carey, L. ... - - J. Clin. Oncol. - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012 , ACRIN-6657

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Esserman, Laura J. , Berry, Donald A. , Cheang, Maggie C. U. ... - - Breast Cancer Res. Treat - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non–small cell lung cancer

Fernando, Hiran C. ... - - J. Thorac. Cardiovasc. Surg. - 2012

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - ACOSOG-Z4099

Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set

Fibla, Juan J. , Cassivi, Stephen D. , Brunelli, Alessandro ... - - Lung Cancer - 2012

Manuscript - Secondary - Primary - Respiratory - ACOSOG-Z0030

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

Franko, Jan , Shi, Qian , Goldman, Charles D. , Pockaj, Barbara A. ... - - J Clin Oncol - 2012

Manuscript - Secondary-not-in-original - Comprehensive - GI - N9841 , N9741

Changes in Cognitive Function in Older Women With Breast Cancer Treated with Standard Chemotherapy and Capecitabine within CALGB 49907

Freedman, R. , Pitcher, B. , Keating, N. , Barry, W. , Ballman, K. ... - - Cancer Res. - 2012

Abstract - Secondary - Primary - Older Adult - CALGB-49907

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

Friday, Bret B. , Anderson, S. Keith , Buckner, Jan , Yu, Chunrong ... - - Neuro Oncol - 2012

Manuscript - Primary - Primary - Neuro-Onc - N0779

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)

Gajewski, T. F. , Salama, A. K. , Niedzwiecki, D. , Johnson, J. ... - - J Transl Med - 2012

Manuscript - Primary - Primary - Experimental - CALGB-500104

Treatment-influenced associations of PML-RARalpha mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia

Gallagher, R. E. , Moser, B. K. , Racevskis, J. , Poire, X. ... - - Blood - 2012

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C9710

A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for T2N0 Rectal Cancer: Preliminary Results of the ACOSOG Z6041 Trial

Garcia-Aguilar, Julio , Shi, Qian , Thomas, Charles R. , Chan, Emily ... - - Ann. Surg. Oncol. - 2012

Manuscript - Primary - Preliminary - GI - ACOSOG-Z6041

Accuracy of FDG-PET to diagnose lung cancer in the ACOSOG Z4031 trial

Grogan, E. , Deppen, S. , Ballman, K. , Andrade, G. , Verdail, F. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4031

LACE-Bio Pooled Analysis of the Prognostic and Predictive Value of TP53 mutations in Completely Resected Non Small Cell Lung Cancer (NSCLC)

Hainaut, P. , Ma, X. , Lacas, B. , Tsao, M. , Douillard, J.-Y. ... - ESMO - - 2012

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-9633

Relationship of opioid analgesic (OA) use at 3 months and overall survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Halabi, S. , Kelly, W. K. , Kaplan, E. B. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90401

Evaluating the effect of tobacco on prostate cancer outcomes with VEGF-targeted therapy

Harzstark, A. L. , Halabi, S. , Kelly, W. K. , Morris, M. J. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90401

A comparison of two methodologies to quantify Thymidylate synthase for predicting survival in patients with colorectal cancer treated on CALGB 89803

Hasson, R. M. , Niedzwiecki, D. ... - AACR - Cancer Res. - 2012

Abstract - Secondary - Primary - GI - CALGB-89803

CALGB 30704: A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small cell lung cancer (NSCLC)

Heist, R. C. Suk , Wang, X. , Hodgson, L. D. , Otterson, G. A. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Respiratory - CALGB-30704

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial

Holtan, Shernan G. , Steen, Preston D. , Foster, Nathan R. ... - - PLoS ONE - 2012

Manuscript - Primary - Primary - Experimental - N004E

Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set

Hubbard, Joleen , Thomas, David M. , Yothers, Greg , Green, Erin ... - - J. Clin. Oncol - 2012

Manuscript - Secondary - Comprehensive - GI - ACCENT , CALGB-89803

Factors Associated with Local-Regional Recurrence Following a Negative Sentinel Node Dissection: Results of the ACOSOG Z0010 Trial

Hunt, Kelly K. , Ballman, Karla V. , McCall, Linda M. ... - - Ann. Surg. - 2012

Manuscript - Secondary - Primary - Breast - ACOSOG-Z0010

Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL

Hylton, Nola M. , Blume, Jeffrey D. , Bernreuter, Wanda K. ... - - Radiology - 2012

Manuscript - Primary - Primary - Breast - CALGB-150007

A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303

Innocenti, Federico , Owzar, Kouros , Cox, Nancy L. , Evans, Patrick ... - - Clin. Cancer Res. - 2012

Manuscript - Secondary - Primary - PPP - CALGB-151006 , CALGB-80303

Phase I Trial of Rituximab, Cladribine and Temsirolimus (RCT) for Initial Therapy of Mantle Cell Lymphoma

Inwards, D. J. , Fishkin, P. , Laplant, B. R. , Drake, M. T. ... - ASH - ASH Annual Meeting Abstracts - 2012

Abstract - Primary - Primary - Lymphoma - N078D

Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

Jahan, Thierry , Gu, Lin , Kratzke, Robert , Dudek, Arkadiusz ... - - Lung Cancer - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30107

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

Janne, P. A. , Wang, X. F. , Socinski, M. A. , Crawford, J. ... - - J. Clin. Oncol. - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30406

Prognostic and Predictive Values of KRAS in EGFR-based Subgroups and Combined with P53 in Completely Resected Non-Small Cell Lung Cancer (NSCLC): a LACE-Bio Study

Janne, P. , Shepherd, F. , Domerg, C. , Le Teuff, G. , Kratzke, R. ... - - Ann. Oncol. - 2012

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites (N04C2)

Jatoi, Aminah , Nieva, Jorge J. , Qin, Rui , Loprinzi, Charles L. ... - - Oncology - 2012

Manuscript - Primary - Primary - Symptom Inter - N04C2

Liver metastases (LM) to predict for short overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts)

Kelly, W. K. , Halabi, S. , Carducci, M. A. , George, D. J. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90401

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

Kelly, William Kevin , Halabi, Susan , Carducci, Michael ... - - J. Clin. Oncol - 2012

Manuscript - Primary - Primary - GU - CALGB-90401

North Central Cancer Treatment Group phase II study of panitumumab (Pmab), chemotherapy, and external beam radiation (Chemo-RT) in patients with locally advanced (LA) pancreatic cancer

Kim, G. P. , Foster, N. R. , Haddock, M. G. , Dakhil, S. R. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - GI - N064A

Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer (BC)

Klepin, H. D. , Pitcher, B. , Ballman, K. V. , Kimmick, G. G. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary - Primary - Older Adult - CALGB-70103 , CALGB-49907

Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

Kostakoglu, Lale , Schöder, Heiko , Johnson, Jeffrey L ... - - Leuk. Lymphoma - 2012

Manuscript - Secondary - Primary - Lymphoma - CALGB-50203

FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group

Kutny, M. A. , Moser, B. K. , Laumann, K. , Feusner, J. H. , Gamis, A. ... - - Pediatr Blood Cancer - 2012

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C9710

Phase I randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM): Final results of phase I study

Laack, N. N. , Galanis, E. , Leinweber, C. , Buckner, J. C. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Primary - Preliminary - Neuro-Onc - N0877

Utility of circulating biomarkers as outcome predictors in metastatic colorectal cancer and recurrent glioblastoma multiforme patients treated with bevacizumab/sorafenib

Lafky, J. M. , Anderson, S. K. , Morlan, B. W. , Nelson, G. D. ... - AACR - Cancer Res. - 2012

Abstract - Secondary-not-in-original - Primary - GI - N054C

Multicenter I-SPY 1 TRIAL (CALGB 150007/150012): Breast cancer stem cells are associated with intrinsic chemoresistance and worse survival

Landis, M. , Yau, C. , Neumeister, V. , Rimm, D. , Esserman, L. ... - - Cancer Res. - 2012

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012

Role of axillary ultrasound after neoadjuvant chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis (ACOSOG Z1071)

Le-Petross, H. T. , Mccall, L. , Hunt, K. , Mittendorf, E. A. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

CALGB 50401: A randomized trial of lenalidomide alone versus lenalidomide plus rituximab in patients with recurrent follicular lymphoma.

Leonard, J. , Jung, S.-H. , Johnson, J. L. , Bartlett, N. L. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Lymphoma - CALGB-50401

Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML

Li, Z. , Huang, H. , Li, Y. , Jiang, X. , Chen, P. , Arnovitz, S. ... - - Blood - 2012

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C9665

Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840

Lichtman, S. M. , Hurria, A. , Cirrincione, C. T. , Seidman, A. D. ... - - Ann. Oncol - 2012

Manuscript - Secondary-not-in-original - Meta-Analysis - Breast - CALGB-9342 , CALGB-9840

Impact of a Telephone-Based Physical Activity Intervention upon Exercise Behaviors and Fitness in Cancer Survivors Enrolled in a Cooperative Group Setting

Ligibel, Jennifer A. , Meyerhardt, Jeffrey , Pierce, John P. ... - - Breast Cancer Res. Treat. - 2012

Manuscript - Primary - Primary - Prevention - NCT00548236

A Phase II Study Of Induction Chemotherapy Followed By Thoracic Radiotherapy (TRT) And Erlotinib In Poor-risk Stage III Non-small Cell Lung Cancer (NSCLC): Initial Results Of CALGB 30605 And RTOG 0972

Lilenbaum, R. , Samuels, M. , Kong, F. , Wang, X. , Janne, P. ... - - J Thorac Oncol - 2012

Abstract - Primary - Primary - Respiratory - CALGB-30605

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)

Lin, Cheryl , Buxton, Meredith Becker , Moore, Dan , Krontiras, Helen ... - - Breast Cancer Res. Treat. - 2012

Manuscript - Secondary - Primary - Breast - CALGB-150007 , CALGB-150012

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer

Lips, Esther H. , Mukhtar, Rita A. , Yau, Christina ... - - Breast Cancer Res. Treat. - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

Liu, Hongtao , Johnson, Jeffrey L. , Koval, Greg , Malnassy, Greg ... - - Haematologica - 2012

Manuscript - Secondary - Primary - Lymphoma - CALGB-59909

PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy

Liu, M. , Pitcher, B. , Mardis, E. , Davies, S. , Snider, J. ... - AACR - Cancer Res. - 2012

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-9741

The genetic landscape of mutations in Burkitt lymphoma

Love, Cassandra , Sun, Zhen , Jima, Dereje , Li, Guojie , Zhang, Jenny ... - - Nat. Genet. - 2012

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-10002

Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study

Lozanski, Gerard , Ruppert, Amy S. , Heerema, Nyla A. ... - - Leuk. Lymphoma - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-9712 , CALGB-9665

NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial.

Ma, D. , Galanis, E. , Schiff, D. , Wu, W. , Peller, P. J. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Long-Term-Followup - Neuro-Onc - N057K

Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901

Mandelblatt, J. S. , Faul, L. A. , Luta, G. , Makgoeng, S. B. ... - - J. Clin. Oncol. - 2012

Manuscript - Secondary - Primary - Older Adult - CALGB-369901

Impact of disease progression (DP) date determination method on post progression survival (PPS) and DP metrics in advanced lung cancer

Mandrekar, Sumithra J. , Foster, Nathan R. , Qi, Yingwei ... - ASCO - J. Clin. Oncol. - 2012

Abstract - No-Endpoint - Comprehensive - Respiratory - N0424

Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia

Marcucci, Guido , Metzeler, Klaus H. , Schwind, Sebastian ... - - J. Clin. Oncol. - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-9621 , CALGB-19808

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

McCarthy, Philip L. , Owzar, Kouros , Hofmeister, Craig C. ... - - N. Engl. J. Med. - 2012

Manuscript - Primary - Primary - Myeloma - CALGB-100104

Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence

Mccarter, M. D. , Antonescu, C. R. , Ballman, K. V. , Maki, R. G. ... - - J. Am. Coll. Surg. - 2012

Manuscript - Secondary-not-in-original - Comprehensive - GI - ACOSOG-Z9000 , ACOSOG-Z9001

Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial

Mcwilliams, R. R. , Mahoney, M. R. , Marchello, B. T. , Jatoi, A. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - GI - N0543

A comprehensive analysis of clinical and tumor characteristics with BRAF and KRAS mutations status in adjuvant colon cancer trial N0147.

Mcwilliams, R. R. , Mahoney, M. R. , Sargent, D. J. , Nelson, G. D. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - N0147

RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

Mendler, Jason H. , Maharry, Kati , Radmacher, Michael D. ... - - J. Clin. Oncol. - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - C8525 , CALGB-8461 , CALGB-8923 , CALGB-9420 , CALGB-9621 , CALGB-9665 , CALGB-9720 , CALGB-10201 , CALGB-19808 , CALGB-20202

Dietary Glycemic Load and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings From CALGB 89803

Meyerhardt, J. A. , Sato, K. , Niedzwiecki, D. , Ye, C. , Saltz, L. B. ... - - J Natl Cancer Inst - 2012

Manuscript - Secondary - Primary - Prevention - CALGB-159806 , CALGB-89803

Evaluation of the stage IB designation of the 7th edition of the AJCC staging system: Biologic factors are more important

Mittendorf, E. , Ballman, K. , Mccall, L. , Hansen, N. , Lucci, A. ... - ASCO - Cancer Res. - 2012

Abstract - Secondary - Primary - Breast - ACOSOG-Z0010

Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: Results of Cancer and Leukemia Group B (CALGB) 9782

Monk, J.P. , Halabi, S. , Picus, J. , Hussain, A. , Philips, G. ... - - Cancer - 2012

Manuscript - Primary - Primary - GU - CALGB-9782

N0937 (Alliance): Preliminary results of a phase II clinical trial of cisplatin and the novel agent brostallicin in patients with metastatic triple negative breast cancer (mTNBC)

Moreno-Aspitia, A. , Rowland, K. M. Jr , Allred, J. B. , Liu, H. ... - AACR - Cancer Res. - 2012

Abstract - Primary - Preliminary - Breast - N0937

Salvage Therapy with Bortezomib Plus Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma: Initial Results of a Phase II Trial (Alliance/CALGB 50501)

Morrison, V. A. , Jung, S.-H. , Johnson, J. , Lacasce, A. ... - ASH - ASH Annual Meeting Abstracts - 2012

Abstract - Primary - Preliminary - Lymphoma - CALGB-50501

Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

Mrózek, Krzysztof , Marcucci, Guido , Nicolet, Deedra ... - - J. Clin. Oncol. - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-10201 , CALGB-19808 , CALGB-8461 , CALGB-8525 , CALGB-8923 , CALGB-9420 , CALGB-9621 , CALGB-9720

Who Participates in an Adult Cooperative Group Trial for Adolescent and Young Adults (AYAs)? Baseline Demographic and Psychosocial Characteristics of AYAs Enrolled On Intergroup Trial C10403 for Acute Lymphoblastic Leukemia (ALL)

Muffly, L. S. , Stock, W. , Breitenbach, K. , Mulkey, F. , Luger, S. ... - ASH - Blood - 2012

Abstract - Secondary-not-in-original - Primary - Disparities - CALGB-10403 , C10403

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Ogino, Shuji , Shima, Kaori , Meyerhardt, Jeffrey A. ... - - Clin Cancer Res - 2012

Manuscript - Secondary - Primary - GI - CALGB-150705 , C89803

Randomized Clinical Trial of Imiquimod: An Adjunct to Treating Cervical Dysplasia

Pachman, Deirdre R. , Barton, Debra L. , Clayton, Amy H. ... - - Am J Obstet Gynecol - 2012

Manuscript - Primary - Primary - Prevention - NCCTG-989251

Predictive genomic markers to chemotherapy and adjuvant trastuzumab via whole genome expression DASL profiling in the N9831 adjuvant study

Perez, E. , Eckel-Passow, J. , Ballman, K. , Anderson, S. ... - AACR - Cancer Res. - 2012

Abstract - Secondary-not-in-original - Primary - Breast - N9831

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

Perez, Edith A. , Dueck, Amylou C. , McCullough, Ann E. ... - - J Natl Cancer Inst - 2012

Manuscript - Secondary - Primary - Breast - N9831

Smoking status and prognosis in patients with stage III colon cancer: A correlative analysis of NCCTG phase III trial N0147

Phipps, A. I. , Shi, Q. , Limburg, P. L. J. , Nelson, G. D. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary - Primary - GI - N0147

A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes1:NCCTG N08C7

Pruthi, Sandhya , Qin, Rui , Terstreip, Shelby A. , Liu, Heshan ... - - Menopause - 2012

Manuscript - Primary - Primary - Symptom Inter - N08C7

Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer

Qi, Y. , Ziegler, K. L. Allen , Hillman, S. L. , Redman, M. W. ... - - Cancer - 2012

Manuscript - Secondary-not-in-original - Comprehensive - Respiratory - N0022 , N0026 , N0222 , N0323 , N0326 , N0426 , N0528 , N0626 , N0821 , N9921

A phase II study of neoadjuvant therapy with cisplatin, docetaxel, panitumumab plus radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)

Reed, C. , Decker, P. , Schefter, T. , Meyers, B. , Ferguson, M. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Preliminary - GI - ACOSOG-Z4051

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.

Reeves, Brandi N , Dakhil, Shaker R , Sloan, Jeff A , Wolf, Sherry L ... - - Cancer - 2012

Manuscript - Secondary - Long-Term-Followup - Symptom Inter - N08C1

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials

Reiman, T. , Lai, R. , Veillard, A. S. , Paris, E. , Soria, J. C. ... - - Ann. Oncol. - 2012

Manuscript - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.

Reungwetwattana, Thanyanan , Molina, Julian R ... - - J Thorac Oncol - 2012

Manuscript - Primary - Primary - Respiratory - N0323

EGFR expression measured by quantitative immunofluorescense is associated with decreased benefit from trastuzumab in the adjuvant setting in the NCCTG (Alliance) N9831 trial.

Rimm, D. L. , Ballman, K. , Cheng, H. , Vassilakopoulou, M. , Chen, B. ... - - Cancer Res. - 2012

Abstract - Secondary - Primary - Correl Sci NOS - N9831

Identification of Potential Prognostic Biomarkers in Patients with Untreated, Advanced Pancreatic Cancer from a Phase III Trial (CALGB 80303)

Roberts, Andrew S. , Campa, Michael J. , Gottlin, Elizabeth B. ... - - Cancer - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-80303

Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).

Romanus, Dorothy , Kindler, Hedy L , Archer, Laura , Basch, Ethan ... - - J Pain Symptom Manage - 2012

Manuscript - Secondary-not-in-original - Primary - Health Outcome - CALGB-80303

Trastuzumab plus adjuvant chemotherapy for HER2-positive breast cancer: Final planned joint analysis of overall survival (OS) from NSABP B-31 and NCCTG N9831

Romond, E. H. , Suman, V. J. , Jeong, J.-H. , Sledge, G. ... - - Cancer Res. - 2012

Abstract - Primary - Comprehensive - Breast - N9831

BCL6 Expression and Treatment Delay Correlate with Adverse Outcome in Newly Diagnosed Primary CNS Lymphoma: Final Report of CALGB 50202 (Alliance)

Rubenstein, J. L. , Hsi, E. D. , Johnson, J. L. , Jung, S.-H. ... - ASH - ASH Annual Meeting Abstracts - 2012

Abstract - Secondary - Primary - Lymphoma - CALGB-50202

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)

Ruddy, K. J. , Pitcher, B. N. , Archer, L. E. , Cohen, H. J. ... - - Ann. Oncol. - 2012

Manuscript - Secondary - Primary - Experimental - CALGB-49907 , CALGB-60104

CALGB 40502/NCCTG N063H: Randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) with or without bevacizumab (B) as first-line therapy for locally recurrent or metastatic breast cancer (MBC)

Rugo, H. S. , Barry, W. T. , Moreno-Aspitia, A. , Lyss, A. P. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Breast - CALGB-40502 , NCCTG-N063H

An Interim Analysis Of CALGB 150607: Expression And Mutational Status Of c-MET, HGF, EGFR, KRAS, p53, c-CBL, And E-cadherin In Resected Lung Adenocarcinoma Specimens

Salgia, R. , Nallasura, V. , Pang, H. , Rolle, C. , Richards, W. ... - Chicago MSTO - Clin. Cancer Res. - 2012

Abstract - Secondary - Preliminary - Correl Sci NOS - CALGB-150607

Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis

Schild, S. E. , Foster, N. R. , Meyers, J. P. , Ross, H. J. ... - - Ann. Oncol. - 2012

Manuscript - Secondary-not-in-original - Comprehensive - Respiratory - NCCTG-86-20-51 , NCCTG-89-20-51 , NCCTG-89-20-52 , NCCTG-95-20-53

N0321: A phase II study of bortezomib, paclitaxel, carboplatin, and radiotherapy for locally advanced non-small cell lung cancer

Schild, S. E. , Molina, J. R. , Dy, G. K. , Rowland, K. M., Jr ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Respiratory - NCCTG-N0321

Long-term Survival of Patients (pts) Treated with High-dose Radiotherapy(rt) and Concurrent Chemotherapy for Unresectable Non-small Cell Lung Cancer (nsclc)

Schild, S. , Hillman, S. , Graham, D. , Vora, S. , Garces, Y. ... - MSTO - J Thorac Oncol - 2012

Abstract - Primary - Long-Term-Followup - Respiratory - NCCTG-N0028

Association study of the let-7 microrna-binding site polymorphism in 3-untranslated region (UTR) of the KRAS gene in stage III colon cancers from adjuvant trial NCCTG N0147

Sha, Dan , Lee, Adam , Shi, Qian , Alberts, Steven R. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - NCCTG-N0147

Prognostic and predictive effects of KRAS mutation subtype in completely resected non-small cell lung cancer (NSCLC): A LACE-bio study.

Shepherd, F. A. , Bourredjem, A. , Brambilla, E. , Domerg, C. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

Six cycles of Doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: cancer and leukemia group B 40101

Shulman, L. N. , Cirrincione, C. T. , Berry, D. A. , Becker, H. P. ... - - J. Clin. Oncol. - 2012

Manuscript - Primary - Primary - Breast - CALGB-40101

Randomized phase II study of two doses of pixantrone in patients with metastatic breast cancer, N1031 Alliance.

Sideras, K. , Moreno-Aspitia, A. , Tenglin, R. C. , Liu, H. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Breast - NCCTG-N1031

North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane

Sideras, Kostandinos , Dueck, Amylou C. , Hobday, Timothy J. ... - - Clin. Breast Cancer - 2012

Manuscript - Primary - Primary - Breast - NCCTG-N0537

Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy Trials

Sinicrope, Frank A. , Foster, Nathan R. , Yoon, Harry H. ... - - J Clin Oncol - 2012

Manuscript - Secondary-not-in-original - Comprehensive - GI - N994C

Prognostic impact of BRAF and KRAS mutations and their relationship to DNA mismatch repair (MMR) status in 2,686 stage III colon cancer patients (pts) treated in a phase III study of adjuvant FOLFOX +/- cetusimab: NCCTG N0147.

Sinicrope, Frank A. , Mahoney, Michelle R. , Smyrk, Thomas C. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - NCCTG-N0147

Relationship between genetic markers and quality of life (QOL) in stage III colon cancer (CC) patients (pts) prior to adjuvant treatment (N0147).

Sloan, J. A. , Shi, Q. , Lee, A. , Diasio, R. B. , Pavey, E. S. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - Health Outcome - NCCTG-N0147

The impact of prior therapy with ketoconazole (keto) on clinical outcomes after subsequent docetaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) patients: Results from a randomized phase III trial (CALGB 90401).

Small, E. J. , Halabi, S. , Carducci, M. A. , Ryan, C. J. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90401

CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN)

Smith, Ellen M. Lavoie , Pang, Herbert , Cirrincione, Constance ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Onc Nursing - CALGB-170601

Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare Population

Soulos, Pamela R. , Yu, James B. , Roberts, Kenneth B. ... - - J. Clin. Oncol - 2012

Manuscript - Secondary-not-in-original - Primary - Older Adult - CALGB-9343

Phase I study of panobinostat (LBH589) and letrozole in post-menopausal women with metastatic breast cancer.

Tan, W. , Allred, J. , Moreno-Aspitia, A. , Northfeld, D. , Ingle, J. ... - - J. Clin. Oncol. - 2012

Abstract - Primary - Primary - Breast - NCCTG-N093B

Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial

Tan, Winston W. , Allred, Jacob B. , Salim, Muhammad , Flynn, Patrick ... - - Clin. Breast Cancer - 2012

Manuscript - Primary - Primary - Breast - NCCTG-N0337

A novel interaction of genotype, gender and adjuvant treatment in survival after resection of stage III colon cancer: Results of CALGB 89803

Warren, R. S. , Atreya, C. E. , Niedzwiecki, D. , Mayer, R. J. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary - Primary - GI - C89803

Autologous Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Achieves Outcomes Similar to Allogeneic Transplantation - Results of CALGB 10001 (Alliance)

Wetzler, M. , Watson, D. , Stock, W. , Owzar, K. , Koval, G. , Hoke, E. ... - - Blood - 2012

Abstract - Primary - Primary - Leukemia - CALGB-10001

Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)

Whitman, S. , Kohlschmidt, J. , Maharry, K. , Nicolet, D. ... - - Blood - 2012

Abstract - Secondary - Primary - Leuk Corr Sci - CALGB-8461 , CALGB-9665 , CALGB-20202

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

Whitman, SP , Caligiuri, MA , Maharry, K , Radmacher, MD ... - - Leukemia - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-10201 , CALGB-8525 , CALGB-8923 , CALGB-9420 , CALGB-9720

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype

Wilson, W. H. , Jung, S. H. , Porcu, P. , Hurd, D. , Johnson, J. ... - - Haematologica - 2012

Manuscript - Primary - Primary - Lymphoma - CALGB-50103

Gene expression changes associated with response to neoadjuvant chemotherapy are observed early in treatment: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Wolf, D. , Yau, C. , Magbanua, M. , Boudreau, A. , Davis, S. , Haqq, C. ... - - Cancer Res. - 2012

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA

Wolf, S. L. , Barton, D. L. , Qin, R. , Wos, E. J. , Sloan, J. A. ... - - Support Care Cancer - 2012

Manuscript - Secondary - Primary - Health Outcome - N06CA

Relationship between overall survival and progression-free survival for recent NCCTG glioblastoma multiforme trials

Wu, W. , Galanis, E. , Buckner, J. C. , Jaeckle, K. A. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Comprehensive - Neuro-Onc - Comprehensive

Protein pathway activation mapping of I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with HR+/HER2– tumors

Wulfkuhle, J. , Yau, C. , Gallagher, R. , Wolf, D. , Calvert, V. ... - SABCS - Cancer Res. - 2012

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012

Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping

Wulfkuhle, Julia D. , Berg, Daniela , Wolff, Claudia , Langer, Rupert ... - - Clin. Cancer Res. - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007